Analyst Reco. Takeda Pharmaceutical Company Limited Sapporo S.E.

Equities

4502

JP3463000004

Delayed Sapporo S.E. Other stock markets 00:53:52 11/03/2024 GMT			5-day change	1st Jan Change
4,300 ^JPY	-1.15%		-.--%	+8.18%

06-18	Takeda Pharmaceutical Says Results of Phase 3 Trial Support Use of Hyqvia as Maintenance Treatment for CIDP	MT
06-18	Takeda Announces Data from Phase 3 ADVANCE-CIDP 3 Clinical Trial of HYQVIA in Patients with Chronic Inflammatory Demyelinating Polyneuropathy at PNS Annual Meeting	CI

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Toyota becomes Asia's most shorted large-cap stock - Hazeltree	03-12	RE
Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,600 Yen From 5,200 Yen, Keeps at Buy	02-13	MT
Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,200 Yen From 5,300 Yen, Keeps at Buy	03/10/23	MT
Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,300 Yen From 5,100 Yen, Keeps at Buy	22/09/23	MT
Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,100 Yen From 5,000 Yen, Keeps at Buy	31/05/23	MT
TD Cowen Adjusts Price Target on Takeda Pharmaceutical to $20 From $30, Maintains Outperform Rating	16/05/23	MT
TD Cowen Adjusts Price Target on Takeda Pharmaceutical to $30 From $24, Keeps Outperform Rating	04/04/23	MT
BofA Securities Upgrades Takeda Pharmaceutical to Buy From Neutral, Price Target $20	16/03/23	MT
Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,000 Yen From 4,600 Yen, Keeps at Buy	06/03/23	MT
Jefferies Downgrades Takeda Pharmaceutical to Hold From Buy	01/08/22	MT
Cowen Upgrades Takeda Pharmaceutical to Outperform From Market Perform	19/07/22	MT
TAKEDA PHARMACEUTICAL : Morgan Stanley Downgrades Takeda Pharmaceutical to Equal-weight From Overweight	07/10/21	MT
Japan Petroleum Exploration : Japanese shares end higher on Wall Street gains, stable U.S. rates	21/05/21	RE
Japanese shares fall on profit booking, checking U.S. rates	06/04/21	RE
Takeda Pharmaceutical : Says Phase 3 Study Results Show Takhzyro Curbed HAE Attack Rate Long Term	13/11/20	MT
Takeda Pharmaceutical Company Limited: Takeda Reports Strong First Quarter FY2019 Results and Raises Guidance for the Full Year	31/07/19	EQ
Takeda Pharmaceutical : Reports Strong First Quarter FY2019 Results and Raises Guidance for the Full Year	31/07/19	BU
Takeda Pharmaceutical : Announces Execution of Loan Agreement in Connection with Proposed Acquisition of Shire plc	03/12/18	BU
Takeda Pharmaceutical : Announces Execution of Senior Short Term Loan Facility Agreement and Subordinated Syndicated Loan Agreement and Second Amendment to Bridge Credit Agreement in Connection with Proposed Acquisition of Shire plc	26/10/18	BU
BAYER : Germany's Merck hires JP Morgan to sell consumer health	08/09/17	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Takeda Pharmaceutical Company Limited Sapporo S.E.

Equities

4502

JP3463000004

Analyst Reco.

Filters